Skip to main content

Market Overview

Mid-Morning Market Update: Markets Open Higher; Morgan Stanley Beats Q4 Expectations


Following the market opening Wednesday, the Dow traded up 0.62% to 31,121.40 while the NASDAQ rose 1.70% to 13,421.43. The S&P also rose, gaining 1.10% to 3,840.51.

The U.S. has the highest number of coronavirus cases and deaths in the world, reporting a total of 24,254,280 cases with around 401,770 deaths. India confirmed a total of at least 10,595,630 confirmed cases and 152,710 deaths, while Brazil reported over 8,573,860 COVID-19 cases with 211,490 deaths. In total, there were at least 96,269,160 cases of COVID-19 worldwide with over 2,059,560 deaths, according to data compiled by Johns Hopkins University.

Leading and Lagging Sectors

Communication services shares gained by 2.6% on Wednesday. Meanwhile, top gainers in the sector included Qutoutiao Inc - ADR (NASDAQ: QTT), up 21%, and Netflix Inc
(NASDAQ: NFLX), up 13%.

In trading on Wednesday, financial shares fell 0.5%.

Top Headline

Morgan Stanley (NYSE: MS) reported stronger-than-expected results for its fourth quarter.

Morgan Stanley reported quarterly earnings of $1.92 per share, beating analysts’ expectations of $1.27 per share. The company posted managed revenue of $13.60 billion, versus estimates of $11.54 billion.


Equities Trading UP

Obalon Therapeutics, Inc. (NASDAQ: OBLN) shares shot up 75% to $2.81 after the company announced a merger agreement with ReShape Lifesciences.

Shares of Daré Bioscience, Inc. (NASDAQ: DARE) got a boost, shooting 39% to $3.29 after climbing around 64% on Tuesday. Dare Bioscience, earlier during the month, filed for offer and sale of up to 6.4 million shares of common stock by Lincoln Park Capital Fund.

Gritstone Oncology, Inc. (NASDAQ: GRTS) shares were also up, gaining 51% to $33.53. Gritstone and Genevant Sciences reported a license agreement for COVID-19 vaccine. The company’s shares jumped over 248% on Tuesday after the company announced that it is advancing development of a second generation vaccine against SARS-CoV-2, with potential for both prolonged protection and potency against spike mutants.

Check out these big movers of the day

Equities Trading DOWN

Document Security Systems, Inc. (NYSE: DSS) shares tumbled 31% to $3.8122 after the company priced a $24 million upsized public offering of common stock.

Shares of China Natural Resources, Inc. (NASDAQ: CHNR) were down 27% to $1.70 after the company reported an offering of $7.3 million of common shares at $1.85 per share.

BioLineRx Ltd.. (NASDAQ: BLRX) was down, falling 21% to $2.50 after the company increased its earlier announced bought deal offering to $30 million.


In commodity news, oil traded up 1.2% to $53.59, while gold traded up 0.6% to $1,851.90.

Silver traded up 0.5% Wednesday to $25.445 while copper rose 0.4% to $3.6470.

Euro zone

European shares were mostly higher today. The eurozone’s STOXX 600 rose 0.6%, the Spanish Ibex Index fell 0.4% and the German DAX 30 gained 0.6%. Meanwhile, the French CAC 40 rose 0.5%, London’s FTSE 100 rose 0.1% and Italy’s FTSE MIB gained 0.6%.

UK’s producer prices declined 0.4% year-over-year, while inflation rate increased to 0.6% in December. Germany's producer prices rose 0.2% year-over-year in December.


The Johnson Redbook Retail Sales Index fell 2.5% during the first two weeks of January versus December.

The NAHB housing market index declined 3 points to a reading of 83 in January.

The Treasury is set to auction 20-year bonds at 1:00 p.m. ET.

Check out the full economic calendar here


Related Articles (CHNR + BLRX)

View Comments and Join the Discussion!

Posted-In: Earnings News Penny Stocks Eurozone Commodities Small Cap Global Intraday Update

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at